Nineteen years after the identification of mutations in the gene which cause cystic fibrosis, European researchers have identified fifteen potential repair molecules

Improving the long-term health prospects of transplant patients has proved an elusive target so far. But now, new tests and techniques are being investigated that could reduce the number of immunosuppressive drugs transplant patients need to take